Financial

Red Spotlight: Phio Pharmaceuticals Corp. (NASDAQ:PHIO)

Spread the love

Phio Pharmaceuticals Corp. (NASDAQ: PHIO) noticed downward change of -3.12% to $0.45 along volume of 250539 shares in recent session compared to an average volume of 685.73K. The stock observed return of -2.89% in 5 days trading activity. The stock was at 8.14% over one month performance. PHIO’s shares are at 32.86% for the quarter and driving a -84.60% return over the course of the past year and is now at 40.95% since this point in 2018.

The average volatility for the week at 5.02% and for month was at 6.98%. There are 22.5M shares outstanding and 16.84M shares are floated in market. Right now the stock beta is 2.04.

Phio Pharmaceuticals Corp. (NASDAQ: PHIO) reported the appointment of Dr. John A. Barrett as the Company’s Chief Development Officer effective as of April 22nd.

Dr. Gerrit Dispersyn, President and CEO of Phio Pharmaceuticals said “I am delighted to welcome John to Phio. John is a seasoned and passionate leader who brings a wealth of experience developing immuno-oncology gene and cell therapies”. “His expertise in driving drug discovery and development in areas similar to Phio’s current R&D focus, will be invaluable as we continue to develop our self-delivering RNAi platform into innovative immuno-oncology therapeutics. I am thrilled to have someone of John’s caliber join our team, which is a testimony to the value we have developed thus far, and the potential our pipeline holds.”

Dr. Barrett added “Phio Pharmaceuticals’ self-delivering RNAi technology is an enticing modality for immuno-oncology therapeutics with a potential to replace or complement certain genetic engineering approaches. For example, the use of this technology holds promise in taking the molecular brakes off the tumor infiltrating T-cells and releasing their full therapeutic potential”. “I am excited to join Phio and welcome the opportunity to be a part of fulfilling the Company’s mission to develop truly innovative cancer treatments.”

Phio Pharmaceuticals Corp. (NASDAQ:PHIO) stock identified change of 66.85% away from 52-week low price and recently located move of -85.70% off 52-week high price. It has market worth of $10.46M . PHIO stock has been recorded 11.42% away from 50 day moving average and -44.37% away from 200 day moving average. Moving closer, we can see that shares have been trading 0.36% off 20-day moving average.

Leave a Reply

Your email address will not be published. Required fields are marked *